Abstract Purpose of Review We reviewed the available literature on mpox in People with
HIV (PWH). We highlight special considerations of mpox infection related to epidemiology …

People living with HIV (PLWH) remain at high risk of mortality and morbidity from vaccine-
preventable diseases, even though antiretroviral therapy (ART) has restored life expectancy …

Whole‐genome sequencing (WGS) has been widely used for the genomic characterization
and the phylogenesis of mpox virus (MPXV) 2022 multi‐country outbreak. To date, no …

Background Following the mpox 2022 outbreak, several high-income countries have
developed plans with inclusion criteria for vaccination against the mpox disease. This study …

Sub-Saharan Africa (SSA) is disproportionately affected by mpox and HIV. We described
epidemiologic trends and clinical experiences in the management of mpox in people living …

The Comment by Isaac Núñez and Sergio Iván ValdésFerrer1 argues that including
fulminant or necrotising mpox (formerly known as monkeypox) as an AIDSdefining condition …

The global mpox outbreak has affected more than 86 000 people in 110 countries, with 96
deaths reported [1]. The outbreak has focused on men who have sex with men, a large …

Background Limited data is available regarding the severity and mortality of Mpox in
individuals with immunocompromised conditions. Therefore, we performed this meta …

Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks
have occurred outside Africa. In 2022, the global spread of cases with sustained interhuman …

Cervical cancer is a significant public health concern globally, with low and middle-income
countries bearing the highest burden, specifically the South Asian region. Therefore, the …